Skip to content
  • 6,809 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Award notice

Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains

75A50125C00008

Office of Assistant Secretary for Preparedness and Response, Aspr Administration for Strategic Preparedness and Response. Research and Development in Biotechnology (except Nanobiotechnology).

Awarded

Osivax

$98,593,151.00 on the award notice, July 25, 2025, contract 75A50125C00008

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one was awarded in 2025

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Osivax
UEI
M4YDKJJRJYC7
CAGE
FBDR2
Vendor location
Paris 8
Contract
75A50125C00008, definitive contract
Obligated
$19,485,392.00, potential $98,593,151
Actions
3 between July 25, 2025 and May 19, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Osivax - Clinical Proof of Concept of OVX836, a Single-Shot Broadly Protective Influenza a Vaccine for Immediate Protection Against Emerging Pandemic Strains
Match
award number 75A50125C00008 equals the contract number; same sub-agency 7505 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 14, 2025

    Award notice, originally solicitation

    Awarded to Osivax for $98,593,151. SAM.gov, notice 1fce5ad56c2d466390a77292391a9d9d

    2 revisions on SAM
    • October 14, 2025: publish, award notice
    • May 29, 2025: publish, solicitation
  2. October 14, 2025

    Award notice, originally solicitation

    Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)

    Awarded to Osivax for $98,593,151. SAM.gov, notice 3d5228ccb02f4c5d94250b1e1f794bac

    2 revisions on SAM
    • October 14, 2025: publish, award notice
    • January 24, 2020: publish, solicitation
  3. October 14, 2025

    Award notice, originally solicitation

    Awarded to Osivax for $98,593,151. SAM.gov, notice d533887fa15e4e9ba22fd7470fb596ee

    2 revisions on SAM
    • October 14, 2025: publish, award notice
    • January 24, 2020: publish, solicitation

Points of contact